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Molecules labeled in green and blue play positive and negative roles in Wnt/β-catenin signaling, respectively. Molecules that are labeled in both colors have dual roles.
(Top left) Wnt biogenesis. A lipid modification is added to Wnt ligands by Porc in the endoplasmic reticulum (ER). Wnt ligands are glycosylated in the ER and Golgi and 
require Wls (also known as Evi) to traffic through the Golgi to the plasma membrane. The retromer complex is also important for Wnt secretion, particularly for long-
range signaling. Mature Wnt ligands may interact with lipoprotein particles. Proteoglycans Dally and Kny/Glypican may also facilitate Wnt distribution.
(Bottom right) Wnt receptor biogenesis. In cells that respond to Wnt the ER protein MESD is required for folding and trafficking of the Wnt receptor LRP5/6 to the plasma 
membrane, and the ER protein Shisa prevents folding and trafficking of the Fz protein to the plasma membrane.
(Right) Wnt/β-catenin signaling OFF. sFRP and WIF1 directly bind Wnt ligands and prevent Wnts from binding to receptors. SOST/WISE, CTGF/Cyr61 bind to LRP6 (CTGF 
may also bind to Fz) to prevent the formation of the Wnt-Fz-LRP5/6 receptor complex. DKK binds to and inhibits LRP5/6 in cooperation with the KRM receptor. In the absence 
of Wnt signaling, the scaffolding protein Axin and tumor suppressor APC form a β-catenin destruction complex that binds cytosolic β-catenin and facilitates sequential phos-
phorylation of β-catenin by CK1 (at S45) and GSK3 (at S33/S37/T41). The tumor suppressor WTX may also reside in this complex. Phosphorylated β-catenin is recognized by 
β-Trcp and ubiquitinated for degradation by the proteasome. In the nucleus, TCF assembles a transcriptional repressor complex to silence Wnt target genes via recruiting Gro, 
CtBP, and HDACs. Residual β-catenin is exported from the nucleus by RanBP3 and APC or bound by CBY or ICAT that prevents β-catenin association with TCF/LEF.
(Left) Wnt/β-catenin signaling ON. The Wnt ligand binds to Fz and LRP5/6 receptors to form a Fz-LRP5/6 complex. Dally and Kny can also bind Wnt and enrich Wnt 
concentration locally or help Wnt gradient distribution. Rspo proteins and Norrin are secreted agonists that bind to LRP5/6 and/or Fz to activate Wnt/β-catenin signaling. 
Formation of the Fz-LRP6 complex via Dvl promotes LRP6 phosphorylation by GSK3 and CK1γ and other CK1. Fz binds Dvl and phosphorylated LRP6 recruits Axin to the 
plasma membrane, resulting in inhibition of β-catenin phosphorylation/degradation by an as yet unknown mechanism. Fz-LRP6-Dvl aggregation may be involved. LRP6 
association with caveolin may promote its endocytosis and signaling. Translocation of Axin is facilitated by MACF1. Trimeric G proteins may act between Fz and Dvl, and 
β-arrestin may associate with Dvl and Axin. Stabilized β-catenin is translocated to the nucleus where it binds TCF/LEF and recruits coactivators such as the Lgs/Pygo 
complex, CBP/p300, Brahma, MED12/Mediator, and the PAF1/Hyrax complex to initiate RNA transcription and elongation. TCF/β-catenin controls the expression of many 
genes that affect cell proliferation (i.e., c-myc, cyclin D1) and differentiation and also the expression of Wnt signaling inhibitory proteins (i.e., Dkk1, Axin2) that act as a nega-
tive feedback loop. In addition to TCF/LEF, β-catenin also binds to other transcription factors such as Prop1 and Pitx2 to coactivate non-TCF/LEF target genes.
Other regulatory molecules
(1) Stimulatory roles: Dvl phosphorylation by CK1ε and Par1 isoforms; GSK3 bindng by GBP/FRAT; Axin dephosphorylation by PP1, which prevents Axin-GSK3 binding. 
(2) Inhibitory roles: Dvl binding by NKD and IDAX; Dvl degradation by Inv and by the KLHL12-CUL3 complex. The primary cilia may suppress Wnt/β-catenin signaling via 
Inv-mediated Dvl degradation and other mechanisms. PP2A may have both stimulatory and inhibitory roles at different steps of the Wnt/β-catenin pathway depending 
on the regulatory subunits (PR55, PR61, PR72, and PR130). Frodo/DPR binds to Dsh/Dvl and may have stimulatory and inhibitory roles. 
Other signaling pathways that affect β-catenin signaling
PKA can phosphorylate β-catenin at S675 and inhibit β-catenin degradation; Akt/PKB can phosphorylate β-catenin at S552 and promote β-catenin nuclear localization. At 
the adherens junction, β-catenin binds to cadherin to coordinate cell adhesion with actin cytoskeleton through α-catenin. Plakoglobin/γ-catenin (not shown) is closely re-
lated to β-catenin although its primary function appears to be at the adherens junction. RTK signaling phosphorylates cadherin-bound β-catenin at Y142 and Y654, via RTK 
and/or c-Src/Fyn/Fer, to promote dissociation of β-catenin from cadherin, resulting in an increase in cytosolic β-catenin and TCF/β-catenin signaling. RTKs (such as the 
PDGF receptor) can directly regulate the Axin complex via c-Abl-mediated phosphorylation of p68 (an RNA helicase), which displaces β-catenin from Axin and promotes 
β-catenin nuclear accumulation/signaling. TCF may be phosphorylated by NLK, which is activated by TAK1, to prevent TCF/β-catenin from binding to DNA.
Abbreviations
Akt/PKB, protein kinase B; APC, adenomatous polyposis coli gene product; α-cat, α-catenin/CTNNA; β-cat, β-catenin/CTNNB1; β-Trcp, β-tranducin repeat containing 
protein/FBXW1; Brm, Brahma/Brg-1; CBP, CREB-binding protein; CBY, chibby; CDH, cadherin; CK1, casein kinase 1; CtBP, C-terminal binding protein; CTGF, connective 
tissue growth factor; CUL3, Cullin3; Cyr61/CCN1; Dally, division abnormally delayed; DKK, dickkopf; DPR, dapper/Frodo; DVl, dishevelled; sFRP, secreted frizzled related 
protein; Evi, evenness interrupted; Fer, FPS/FES-related tyrosine kinase; Fyn, FYN tyrosine kinase; Fz/FZD, frizzled receptor; G, G protein αβγ subunits; GBP, GSK3-binding 
protein/Frat, frequently rearranged in advanced T cell lymphomas; Gro, groucho/TLE, transducin-like enhancer of split; GSK3, glycogen synthase kinase 3; HDAC, histone 
deacetylase; ICAT, inhibitor of β-catenin; IDAX/CXXC4, inhibition of Dvl/Axin complex; Inv, Inversin; KRM, kremen; LEF, lymphoid enhancer-binding factor; Lgs, Legless/
Bcl9 (B cell lymphoma 9); LRP5/6, low-density lipoprotein-related receptor protein 5 or 6; MACF1, microtubule actin crosslinking factor 1; MED12, mediator subunit 12; 
MESD, mesodermal development gene product/Boca; NKD, naked cuticle; NLK, NEMO-like kinase; Norrin, Norrin disease protein; PAF1, parafibromin/hyrax; PAR1, par-1 
kinase; PKA, protein kinase A; Porc, porcupine; PP1, protein phosphatase 1; PP2A, protein phosphatase 2A; PR, protein phosphatase 2A regulatory unit; Pygo, pygopus; 
RanBP3, Ran-binding protein 3; Rspo, R-spondin; SOST, sclerostin; TAK1, TGF beta-activated kinase 1; TCF, T cell factor; WIF, Wnt inhibitory factor; Wls, Wntless.
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